RECQL4 and Rothmund-Thomson syndrome: The RTS-II patients herein described well summarize the remarkable clinical breadth of Rothmund-Thomson syndrome including mild as well as severe phenotypes at high risk for tumor development, primarily dependent on the pathogenic variants at the causative RECQL4 gene.